Company / Current Assets
Outlook Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$17.4M
FY2025
5-year range
$3.3M / $17.9M
FY2021-FY2025
Trend
-3.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $14M to $17M over the past 6 years.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of -0.6%.
Improved from $14M to $17M over the past 6 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.6%, indicating a declining trend.
- In FY2025, current assets decreased 3.1% year-over-year.
- Peak current assets was recorded in FY2020.
- Lowest current assets in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.4M | -3.1% |
| FY2020 | $17.9M | +32.9% |
| FY2019 | $13.5M | +308.8% |
| FY2018 | $3.3M | -15.4% |
| FY2017 | $3.9M | -31.2% |
| FY2016 | $5.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026